Send Story by Email

Ivermectin and mebendazole, 84% benefit in cancer

04-18-2026 • Dr John Campbell - YouTube.com

Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol.

Your First Name

Your Last Name

Your Email Address

Enter one or more email addresses below. Separate multiple addresses with a semicolon (;) or a new line. Maximum 10 email addresses at one time.

To Email Address(es)

Personal Note

Also Send Daily Headlines Newsletter

Freedoms Phoenix

Online Magazine

Join-Us

Newspaper

Phone Apps

Declare Your Independence with Ernest Hancock

REAL TIME SPOT PRICES

Live Broadcast

Declare Your Independence

MENU

Send Story by Email

Ivermectin and mebendazole, 84% benefit in cancer

FreedomsPhoenix.com